Synthetic Biology Industry

The global synthetic biology market was valued at USD 16.22 billion in 2024 and is projected to experience significant growth, with a compound annual growth rate (CAGR) of 17.30% from 2025 to 2030. This growth can be attributed to the emergence of various applications of synthetic biology, particularly in areas such as multiplexed diagnostics, cellular recording, and therapeutic genome editing. As these applications gain traction, they are expected to drive a substantial increase in the demand for synthetic products throughout the forecast period. Moreover, the integration of synthetic biology techniques and products into sectors such as energy and chemicals is anticipated to further enhance overall market growth. As the applications of synthetic biology continue to diversify, its utility is likely to expand, leading to broader adoption and accelerated market development.

The impact of the COVID-19 pandemic has notably amplified the utilization of synthetic biology products over the past two years. In response to the crisis, numerous leading pharmaceutical and biotechnology companies, as well as prominent players in the synthetic biology field, have intensified their research efforts on a global scale. These organizations have employed innovative techniques to produce critical tools such as test kits, therapies, and vaccines for COVID-19. A study by the European Parliament highlights synthetic biology as a developing technology with significant potential applications for addressing COVID-19 infections. Additionally, the U.S. National Institutes of Health has recognized synthetic biology as a crucial tool for expediting vaccine development, underscoring its importance in public health initiatives. This heightened focus on synthetic biology during the pandemic is likely to influence its growth trajectory and expand its applications in the future.

Gather more insights about the market drivers, restrains and growth of the Synthetic Biology Market

Technology Insights

• The PCR segment dominated the market with a substantial share of 07% in 2024, and this trend is anticipated to continue in the coming years. The Polymerase Chain Reaction (PCR) has established itself as a crucial technology in the detection and analysis of specific gene sequences, making it indispensable in various scientific fields.
• Products like Real-time PCR assays are particularly notable for their high sensitivity and specificity, which render them the preferred choice for numerous genomic studies. This advanced technique is widely applied across diverse areas, including DNA cloning, forensic research, and genomics, showcasing its versatility and importance in both research and practical applications.
• Looking ahead, genome editing technology is projected to experience substantial growth, marked by a significant compound annual growth rate (CAGR) from 2025 to 2030. The expansion of gene-editing tools can be largely attributed to the myriad advantages they offer through both synthetic and genetically modified organisms.
• The ability of gene editing techniques to create products with specific traits has revolutionized multiple sectors, including human healthcare, animal healthcare, and agriculture. These advancements not only facilitate enhanced product development but also pave the way for innovative solutions to complex challenges faced in these industries.
• As gene-editing technologies continue to evolve and improve, their impact on research and development is expected to grow even further, unlocking new possibilities for scientific exploration and practical applications across various fields. The continuous refinement of these tools will likely lead to novel breakthroughs that can significantly enhance the efficiency and effectiveness of research endeavors.

Order a free sample PDF of the Synthetic Biology Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com/

Follow Us: LinkedIn | Twitter